<--- Back to Details
First PageDocument Content
Microbiology / Ebola / Ebola virus disease / Mononegavirales / Zoonoses / Center for Biologics Evaluation and Research / National Institute of Allergy and Infectious Diseases / National Institutes of Health / Vaccine / Medicine / Biology / Health
Microbiology
Ebola
Ebola virus disease
Mononegavirales
Zoonoses
Center for Biologics Evaluation and Research
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Vaccine
Medicine
Biology
Health

FOOD AND DRUG ADMINISTRATION Center for Biologics Evaluation and Research May 12, 2015 138th Meeting of the Vaccines and Related Biological Products Advisory Committee Meeting FDA White Oak Conference Center, Building 31

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 51,77 KB

Share Document on Facebook

Similar Documents

Vaccine Impact Modelling Consortium Gavi BMGF Secretariat

Vaccine Impact Modelling Consortium Gavi BMGF Secretariat

DocID: 1xTId - View Document

BIOLOGICAL SCIENCES  Respiratory Virus Study Points to Vaccine Target Scientific Achievement

BIOLOGICAL SCIENCES Respiratory Virus Study Points to Vaccine Target Scientific Achievement

DocID: 1vpI1 - View Document

Research Associate in HIV Vaccinology funded by the Gates Foundation T cell inducing vaccine for HIV ref. W1/MCEID

DocID: 1vlag - View Document

Microsoft Word - Vaccine Administration Record.docx

Microsoft Word - Vaccine Administration Record.docx

DocID: 1vi6k - View Document

THE CANCER REVOLUTION Additional Material for Appendix 1 Francisco Contreras, MD and Daniel Kennedy Contreras Dendritic cell cancer vaccine The most powerful anti-cancer agent is the immune system. In fact, it’s imposs

THE CANCER REVOLUTION Additional Material for Appendix 1 Francisco Contreras, MD and Daniel Kennedy Contreras Dendritic cell cancer vaccine The most powerful anti-cancer agent is the immune system. In fact, it’s imposs

DocID: 1vfY6 - View Document